FDA RETALIATION ALLEGATIONS SHOULD BE INVESTIGATED THROUGH "INDEPENDENT" OUTSIDE PROCESS, REP. BARTON TELLS KESSLER AT OVERSIGHT SUBCOMMITTEE HEARING
Executive Summary
Rep. Barton (R-Tex.) will push for an outside investigative body to handle allegations of retaliation as an element of FDA reform legislation.
You may also be interested in...
FDA Employee Misconduct Charges To Be Investigated By OIG Instead Of Itself
A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011